Minimal toxicity after PBT for prostate and pelvic nodal irradiationresults, proton collaborative group REG001-09 trial.
11/10/2017
/
Publications
/
Toxicity
This PCG study evaluated toxicity outcomes for non-metastatic prostate cancer patients who received pelvic radiation therapy.
The study demonstrated PBT...
Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer.
11/12/2017
/
Publications
/
Chemotherapy
Compared the relative risk of radiation-induced lymphopenia between IMRT and PBT in esophageal cancer (EC) patients undergoing neoadjuvant chemoradiation...
Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
03/03/2017
/
Publications
/
Toxicity
Published in the Green Journal, the researchers in Japan reported outcomes of 83 patients treated with definitive repeated PBT. Patients received a median doses...
Establishing evidence-based indications for proton therapy.
10/11/2016
/
Publications
/
Clinical Trial
PT101
An overview of current clinical trials of proton therapy published in the Red Journal. A total 122 ongoing trials with target enrolment of over 42,000 patients...
Long-term outcomes of proton therapy for previously untreated hepatocellular carcinoma (HCC).
10/03/2017
/
Publications
The Japanese group in University of Tsukuba conducted this retrospective study of 129 patients with stage 0 to C disease (BCLC) treated with proton therapy.
...
PBT in rectal cancer
28/07/2021
/
Publications
/
Clinical Trial
PT101
This review article examined eight original studies with a total of 127 patients. There was significantly less irradiated small bowel with PBT compared to 3DCRT...
Identifying individualized risk profiles for radiotherapy-induced lymphopenia
28/09/2021
/
Publications
A MD Anderson-led study. Using machine learning techniques, this study analyzed the retrospective data of 746 patients with esophageal cancer treated with...
Impact of lymphopenia on the clinical outcomes of esophageal cancer patients
28/10/2021
/
Publications
/
Chemotherapy
A study by the Tsukuba group, Japan. This study retrospectively reviewed 69 patients with esophageal cancer treated with XRT (n=15) and PBT (n= 54) and...
Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.
28/09/2021
/
Publications
A study by the Mayo Clinic group. This study examined the acute CTCAE reported by 55 patients (PRO-CTCAE) with high-risk or unfavorable intermediate-risk...
Show&Tell #4: Gastrointestinal cancers
18/11/2021
/
User Meeting
Watch this Show & Tell on Gastrointestinal cancers.
Dr Andrew J. Wroe, Director of Proton Physics, and Dr Adeel Kaiser, Radiation Oncologist, will share c...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.